Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients
- PMID: 33718488
- PMCID: PMC7898029
- DOI: 10.1183/23120541.00737-2020
Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients
Abstract
Background: In the coronavirus disease 2019 (COVID-19) pandemic, rapid clinical triage is crucial to determine which patients need hospitalisation. We hypothesised that chest computed tomography (CT) and alveolar-arterial oxygen tension ratio (A-a) gradient may be useful to triage these patients, since they reflect the severity of the pneumonia-associated ventilation/perfusion abnormalities.
Methods: A retrospective analysis was performed in 235 consecutive patients suspected for COVID-19. The diagnostic protocol included low-dose chest CT and arterial blood gas analysis. In patients with CT-based COVID-19 pneumonia, the association between "need for hospitalisation" and A-a gradient was investigated by a multivariable logistic regression model. The A-a gradient was tested as a predictor for need for hospitalisation using receiver operating characteristic curve analysis and a logistic regression model.
Results: 72 out of 235 patients (mean±sd age 55.5±14.6 years, 40% female) screened by chest CT showed evidence for COVID-19 pneumonia. In these patients, A-a gradient was shown to be a predictor of need for hospitalisation, with an optimal decision level (cut-off) of 36.4 mmHg (95% CI 0.70-0.91, p<0.001). The A-a gradient was shown to be independently associated with need for hospitalisation (OR 1.97 (95% CI 1.23-3.15), p=0.005; A-a gradient per 10 points) from CT severity score (OR 1.13 (95% CI 0.94-1.36), p=0.191), National Early Warning Score (OR 1.19 (95% CI 0.91-1.57), p=0.321) or peripheral oxygen saturation (OR 0.88 (95% CI 0.68-1.14), p=0.345).
Conclusion: Low-dose chest CT and the A-a gradient may serve as rapid and accurate tools to diagnose COVID-19 pneumonia and to select mildly symptomatic patients in need for hospitalisation.
Copyright ©The authors 2021.
Conflict of interest statement
Conflict of interest: M.P. de Roos has nothing to disclose. Conflict of interest: I.D. Kilsdonk has nothing to disclose. Conflict of interest: P-P.W. Hekking has nothing to disclose. Conflict of interest: J. Peringa has nothing to disclose. Conflict of interest: N.G. Dijkstra has nothing to disclose. Conflict of interest: P.W.A. Kunst has nothing to disclose. Conflict of interest: P. Bresser has nothing to disclose . Conflict of interest: H.J. Reesink has nothing to disclose.
Figures
References
-
- World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Clinical management of COVID-19. Interim guidance. 27 May 2020. Geneva, WHO.
-
- Moammar MQ, Azam HM, Blamoun AI, et al. Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalised with community acquired pneumonia. Clin Exp Pharmacol Physiol 2008; 35: 1032–1037. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources